We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.15%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
–
Cap. Flow
+$97.1M
Cap. Flow
% of AUM
93.05%
Top 10 Holdings %
Top 10 Hldgs %
4.92%
Holding
1,330
New
1,330
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRC Group Holdings
RILY
|
+$733K |
| 2 |
iHeartMedia
IHRT
|
+$672K |
| 3 |
Taysha Gene Therapies
TSHA
|
+$581K |
| 4 |
NextDecade
NEXT
|
+$540K |
| 5 |
Appian
APPN
|
+$466K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.72% |
| 2 | Technology | 15.99% |
| 3 | Industrials | 14.77% |
| 4 | Financials | 13.46% |
| 5 | Consumer Discretionary | 12.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iHeartMedia
IHRT
$597M
| $710K | 0.68% |
+265,778
| New | +$672K |
|
|
2
NextDecade
NEXT
$2.04B
| $553K | 0.53% |
+116,026
| New | +$540K |
|
3
American Well
AMWL
$210M
| $535K | 0.51% |
+17,955
| New | +$441K |
|
|
4
BRC Group Holdings
RILY
$276M
| $526K | 0.5% |
+25,051
| New | +$733K |
|
|
5
Taysha Gene Therapies
TSHA
$1.6B
| $516K | 0.49% |
+291,616
| New | +$581K |
|
6
Lexicon Pharmaceuticals
LXRX
$1.03B
| $496K | 0.48% |
+323,968
| New | +$385K |
|
7
Atlas Lithium Corp
ATLX
$83.2M
| $463K | 0.44% |
+14,799
| New | +$383K |
|
|
8
Appian
APPN
$1.91B
| $449K | 0.43% |
+11,934
| New | +$466K |
|
9
ANI Pharmaceuticals
ANIP
$1.77B
| $444K | 0.43% |
+8,052
| New | +$443K |
|
|
CMPS
10
Compass Pathways
CMPS
$1.57B
| $437K | 0.42% |
+49,959
| New | +$323K |
|
11
Wheels Up
UP
$233M
| $397K | 0.38% |
+5,789
| New | +$224K |
|
12
Energy Recovery
ERII
$437M
| $364K | 0.35% |
+19,346
| New | +$359K |
|
13
Forestar Group
FOR
$1.44B
| $347K | 0.33% |
+10,489
| New | +$304K |
|
|
NXDR
14
Nextdoor Holdings
NXDR
$927M
| $343K | 0.33% |
+181,327
| New | +$320K |
|
15
Bridgewater Bancshares
BWB
$612M
| $339K | 0.32% |
+25,070
| New | +$264K |
|
|
BCYC
16
Bicycle Therapeutics
BCYC
$290M
| $334K | 0.32% |
+18,495
| New | +$306K |
|
17
Xencor
XNCR
$1.39B
| $327K | 0.31% |
+15,419
| New | +$293K |
|
18
Structure Therapeutics
GPCR
$3.34B
| $319K | 0.31% |
+7,835
| New | +$449K |
|
19
AdaptHealth
AHCO
$1.49B
| $317K | 0.3% |
+43,480
| New | +$343K |
|
20
Acco Brands
ACCO
$372M
| $317K | 0.3% |
+52,075
| New | +$276K |
|
21
Preformed Line Products
PLPC
$1.57B
| $316K | 0.3% |
+2,361
| New | +$318K |
|
22
Prime Medicine
PRME
$551M
| $312K | 0.3% |
+35,235
| New | +$271K |
|
23
Conduent
CNDT
$248M
| $307K | 0.29% |
+84,208
| New | +$266K |
|
24
TriMas Corp
TRS
$1.43B
| $306K | 0.29% |
+12,092
| New | +$299K |
|
|
EB
25
DELISTED
Eventbrite
EB
| $306K | 0.29% |
+36,552
| New | +$296K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
GAM
KFSC
YCM
EntryPoint Capital's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for EntryPoint Capital, which disclosed 1,330 positions worth $104M. Its ten largest holdings account for 4.9% of the portfolio.
Its largest position is BRC Group Holdings: 25,051 shares worth $526K.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Technology and Industrials.
- EntryPoint Capital's largest Q4 2023 buy was BRC Group Holdings: 25,051 shares worth $526K.
- EntryPoint Capital's ten largest holdings make up 4.9% of its $104M portfolio in Q4 2023.
- EntryPoint Capital disclosed 1,330 positions in Q4 2023, its first 13F filing on record.
Based on EntryPoint Capital's 13F filing for Q4 2023, filed 14 Feb 2024.